Tracon Licenses D93 Antibody From Micromet March 19, 2007 By Trista Morrison In a deal worth up to $100 million, Micromet Inc. licensed the preclinical anti-angiogenesis monoclonal antibody D93 to privately held Tracon Pharmaceuticals Inc. (BioWorld Today)Read More
Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Nov. 29, 2006 - March 14, 2007 March 19, 2007
RSS